Literature DB >> 19560046

Trafficking of dopamine transporters in psychostimulant actions.

Nancy R Zahniser1, Alexander Sorkin.   

Abstract

Brain dopamine (DA) plays a pivotal role in drug addiction. Since the plasma membrane DA transporter (DAT) is critical for terminating DA neurotransmission, it is important to understand how DATs are regulated and this regulation impacts drug addiction. The number of cell surface DATs is controlled by constitutive and regulated endocytic trafficking. Psychostimulants impact this trafficking. Amphetamines, DAT substrates, cause rapid up-regulation and slower down-regulation of DAT whereas cocaine, a DAT inhibitor, increases surface DATs. Recent reports have begun to elucidate the molecular mechanisms of these psychostimulant effects and link changes in DAT trafficking to psychostimulant-induced reward/reinforcement in animal models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560046      PMCID: PMC3248240          DOI: 10.1016/j.semcdb.2009.01.004

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  79 in total

1.  The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

Authors:  M J Nirenberg; J Chan; A Pohorille; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.

Authors:  S J Zhu; M P Kavanaugh; M S Sonders; S G Amara; N R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

3.  Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.

Authors:  J M Kokoshka; R A Vaughan; G R Hanson; A E Fleckenstein
Journal:  Eur J Pharmacol       Date:  1998-11-20       Impact factor: 4.432

4.  Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.

Authors:  B G Garcia; Y Wei; J A Moron; R Z Lin; J A Javitch; A Galli
Journal:  Mol Pharmacol       Date:  2005-03-28       Impact factor: 4.436

5.  Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.

Authors:  Tatiana Sorkina; Brian R Hoover; Nancy R Zahniser; Alexander Sorkin
Journal:  Traffic       Date:  2005-02       Impact factor: 6.215

6.  Membrane trafficking regulates the activity of the human dopamine transporter.

Authors:  H E Melikian; K M Buckley
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

7.  Rapid and reversible effects of methamphetamine on dopamine transporters.

Authors:  A E Fleckenstein; R R Metzger; D G Wilkins; J W Gibb; G R Hanson
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

8.  Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Authors:  Z B Pristupa; F McConkey; F Liu; H Y Man; F J Lee; Y T Wang; H B Niznik
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

9.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.

Authors:  B Giros; M Jaber; S R Jones; R M Wightman; M G Caron
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

10.  Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.

Authors:  S M Hersch; H Yi; C J Heilman; R H Edwards; A I Levey
Journal:  J Comp Neurol       Date:  1997-11-17       Impact factor: 3.215

View more
  36 in total

1.  Dopaminergic reward system: a short integrative review.

Authors:  Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal:  Int Arch Med       Date:  2010-10-06

2.  Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons.

Authors:  Anjali Rao; Toni L Richards; Diana Simmons; Nancy R Zahniser; Alexander Sorkin
Journal:  FASEB J       Date:  2012-01-20       Impact factor: 5.191

3.  Cocaine facilitates PKC maturation by upregulating its phosphorylation at the activation loop in rat striatal neurons in vivo.

Authors:  Bing Xue; Ming-Lei Guo; Dao-Zhong Jin; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2011-11-13       Impact factor: 3.252

4.  Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons.

Authors:  Anjali Rao; Diana Simmons; Alexander Sorkin
Journal:  Mol Cell Neurosci       Date:  2010-09-15       Impact factor: 4.314

5.  Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.

Authors:  Kathleen M Kantak; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2016-03-22       Impact factor: 3.533

6.  Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.

Authors:  Sucharita S Somkuwar; Mahesh Darna; Kathleen M Kantak; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

Review 7.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

8.  Dopamine transporter trafficking: rapid response on demand.

Authors:  Rong Chen; Cheryse A Furman; Margaret E Gnegy
Journal:  Future Neurol       Date:  2010-01-01

9.  Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.

Authors:  Bryan F Singer; Bipasha Guptaroy; Curtis J Austin; Isabella Wohl; Vedran Lovic; Jillian L Seiler; Roxanne A Vaughan; Margaret E Gnegy; Terry E Robinson; Brandon J Aragona
Journal:  Eur J Neurosci       Date:  2016-01-07       Impact factor: 3.386

10.  Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.

Authors:  David A Price; Alexander Sorkin; Nancy R Zahniser
Journal:  Mol Pharmacol       Date:  2009-07-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.